Drug prices have also been a concern for consumers but became a hot-button political issues after a few infamous episodes, including Turing Pharmaceuticals AG decision to raise of the life-saving anti-infective pill Daraprim from $13.50 to $750 after buying the rights to to the medication....
One top dealmaker expected an M&A uptick broadly, but agreed that pharmaceuticals and the financial sector were particularly poised for a resurgence. That deal-maker also noted that with the Senate flipping, more outspoken antitrust voices like Sen. Elizabeth Warren, D-Mass., could find it more...
Pharmaceuticals:Pharma — and the regulation of drug prices specifically — tends to be a political football regardless of which party is in office. However, we expect big pharma will continue to have headline risk from regulatory pressure, with a populist Trump administration eager to demand lower...
Trump announces executive order requiring health care pricing transparency The Trump administration released a plan Friday that would force hospitals and insurers to disclose their negotiate rates or risk being fined. The administration already requires hospitals to publish list prices, sometimes ref...
And doctors and institutions like pharmaceuticals that have been “approved” by the “independent” Food and Drug Administration (FDA); they form a large part of “best practices.” If a malpractice suit is brought against any provider, his, her or its only defense, all things being normal,...
in goods and services last year. He plans to “enact aggressive new restrictions on Chinese ownership” of assets in the United States, ban Americans from investing in China and phase in a ban on importing key categories of Chinese-made goods such as electronics, steel and pharmaceuticals. ...
Ended the costly kickbacks to middlemen and ensured that patients directly benefit from available discounts at the pharmacy counter, saving Americans up to 30 percent on brand name pharmaceuticals. Enhanced Part D plans to provide many seniors with Medicare access to a broad set of insulins at ...
Citius Pharmaceuticals Co-Founder and CEO Discusses the Recently Accepted Biologics License Application of Lymphir for the Treatment of Relapsed/Refractory CTCL The Alliance for a Stronger FDA with Co-founder and Executive Director, Steven Grossman ...
CBS News offers breaking news coverage of today's top headlines. Stay informed on the biggest new stories with our balanced, trustworthy reporting.
one on the U.S. Much of his trade agenda has focused on China. Trump has proposed phasing out Chinese imports of essential goods including electronics, steel and pharmaceuticals and wants to ban Chinese companies from owning U.S. infrastructure in sectors such as energy...